UnitedHealth Group (NYSE:UNH) Shares Down 1% – Here’s What Happened

UnitedHealth Group Incorporated (NYSE:UNH) shares traded down 1% during mid-day trading on Tuesday . The company traded as low as $278.90 and last traded at $282.23. 6,061,804 shares changed hands during trading, a decline of 39% from the average session volume of 9,972,408 shares. The stock had previously closed at $285.17.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Sen. Markwayne Mullin reported a purchase of $50K–$100K of UNH stock on Feb. 25, a visible vote of confidence that can provide short‑term support or investor interest. Trump Ally, New DHS Leader Nominee Markwayne Mullin Makes New Stock Trades
• Neutral Sentiment: UnitedHealth presented at the Barclays Global Healthcare conference (transcript published); presentations typically recap strategy and guidance but rarely move the stock unless new guidance or surprises are announced. UNH Presents at Barclays 28th Annual Global Healthcare Conference Transcript
• Negative Sentiment: Analyst/market writeups and a valuation note highlight recent share‑price weakness and negative total returns over recent periods, renewing investor focus on stretched valuation relative to the pullback. A Look At UnitedHealth Group’s Valuation After Recent Share Price Weakness
• Negative Sentiment: Industry headwinds flagged for HMOs — rising medical costs, workforce shortages and policy uncertainty — increase margin and cost pressure risks for large insurers like UNH. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage
• Negative Sentiment: Weakness at peer Centene tied to ACA marketplace contraction underscores sector vulnerability and can create contagion effects across managed‑care stocks, weighing on investor sentiment toward UNH. Centene Is the Worst S&P 500 Stock Today. What’s Ailing the Health Insurer.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. Evercore upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Morgan Stanley cut their price objective on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a report on Friday, January 23rd. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Oppenheimer lowered their price target on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Finally, UBS Group dropped their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Price Performance

The firm has a 50-day moving average of $305.51 and a 200-day moving average of $325.43. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. The firm has a market capitalization of $252.79 billion, a P/E ratio of 21.10, a PEG ratio of 1.30 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the prior year, the company posted $6.81 earnings per share. The company’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date is Monday, March 9th. UnitedHealth Group’s payout ratio is currently 67.02%.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds have recently modified their holdings of the business. Meadowbrook Advisors Group LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $2,396,000. Larry Mathis Financial Planning LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $365,000. PeakShares LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $429,000. Flax Pond Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $3,839,000. Finally, Lifetime Wealth Management P.C. purchased a new stake in UnitedHealth Group in the 4th quarter worth $29,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.